Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» solid tumors
solid tumors
3T Biosciences Launches $40M at Solid Tumors with TCR Tech
BioSpace
Thu, 08/25/22 - 11:02 am
3T Biosciences
solid tumors
TCRm
GSK turns down one solid tumor collaboration, but Ideaya thinks it’s for the best
Fierce Biotech
Mon, 08/15/22 - 10:26 am
GSK
Ideaya
precision medicine
solid tumors
FDA converts Novartis' NSCLC drug to a full approval with confirmatory data
Endpoints
Thu, 08/11/22 - 11:22 pm
Novartis
Tabrecta
solid tumors
FDA
non-small cell lung cancer
Delfi aims for a cheaper liquid biopsy
EP Vantage
Fri, 08/5/22 - 10:39 am
Delfi Diagnostics
liquid biopsy
diagnostics
Medtech
cancer
solid tumors
Merck's ADC hunt continues with second deal for China biotech Kelun
Endpoints
Tue, 07/26/22 - 05:24 pm
Merck
antibody-drug conjugate
solid tumors
China
Kelun Biotech
QBiotics receives IND application approval for Phase II solid tumours therapy trial
Pharmaceutical Business Review
Mon, 07/25/22 - 10:47 am
QBiotics
clinical trials
FDA
tigilanol tiglate
solid tumors
NexImmune Announces IND Clearance by the US FDA for NEXI-003 for the Treatment of HPV-Related Cancers
BioSpace
Thu, 07/14/22 - 08:01 pm
NexImmune
nanoparticles
solid tumors
NEXI-003
HPV-related cancer
MacroGenics closes solid tumor clinical trial after 7 people die
Fierce Biotech
Mon, 07/11/22 - 10:22 am
clinical trials
Macrogenics
enoblituzumab
solid tumors
patient deaths
Merck to support Transgene and BioInvent led oncolytic virus clinical trial
Biopharma Reporter
Tue, 06/28/22 - 05:51 pm
Merck
Keytruda
clinical trials
Transgene
Bioinvent
solid tumors
Novartis: FDA OKs Tafinlar + Mekinist For Solid Tumors With BRAF V600E Mutation
NASDAQ
Thu, 06/23/22 - 10:57 am
Novartis
FDA
Tafinlar+Mekinist
solid tumors
BRAF V600
Why Clovis Oncology Stock Was Blasting Off Tuesday
Motley Fool
Tue, 06/21/22 - 11:43 pm
Clovis Oncology
clinical trials
FAP-2286
solid tumors
CRISPR Tx Drug Targeting CD70 Offers Early Hope for Difficult T Cell Lymphomas
BioSpace
Mon, 06/13/22 - 10:48 am
CRISPR Therapeutics
clinical trials
CTX130
CAR-T
solid tumors
T-cell lymphoma
ASCO Preview: Immutep, InxMed and Faron Release New Clinical Findings
BioSpace
Tue, 05/31/22 - 10:49 am
ASCO 2022
IMMUTEP
non-small cell lung cancer
InxMed
ovarian cancer
Faron Pharmaceuticals
solid tumors
WMIF panel: How cell and gene therapy can overcome limitations of CAR T
MedCity News
Tue, 05/3/22 - 10:35 am
CAR-T
cell therapy
gene therapy
solid tumors
World Medical Innovation Forum
2 become 1: Caladrius and Cend merge into tumor-focused Lisata Therapeutics
Fierce Biotech
Wed, 04/27/22 - 10:40 am
Caladrius Biosciences
Cend Therapeutics
M&A
solid tumors
Lisata Therapeutics
Four Cancer Clinical Trials Advance with Blessing of FDA
BioSpace
Wed, 03/16/22 - 11:23 pm
cancer
oncology
FDA
clinical trials
Sonnet BioTherapeutics
SON-1010
solid tumors
Adagene
AD126
AIM ImmunoTech
Ampligen
pancreatic cancer
Wugen
WU-CART-007
Novartis puts contract manufacturing ambitions on display with deal to produce Carisma's cell therapy
Fierce Pharma
Thu, 03/10/22 - 10:35 am
Novartis
contract manufacturing
Carisma Therapeutics
solid tumors
CAR-M
Cancer biotech Rondo gets $67M to step on the gas with next-gen bispecific drugs
MedCity News
Fri, 03/4/22 - 09:38 am
Rondo Therapeutics
bispecific antibodies
solid tumors
cancer
funding
Sanofi buys US immuno-oncology biotech Amunix for $1 billion
Pharmaforum
Tue, 12/21/21 - 10:36 am
Sanofi
M&A
Amunix
immuno-oncology
cancer
solid tumors
oncology
Biotech upstart gets $50M to test new virus-based therapies against solid tumors
Endpoints
Thu, 12/9/21 - 10:32 am
OncoMyx
Myxoma virus
solid tumors
funding
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »